Comorbidities common with alopecia areata

Comorbidities common with alopecia areata
Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Kathie P. Huang, M.D., from Brigham and Women's Hospital in Boston, and colleagues retrospectively identified 3,568 individuals with alopecia areata seen in the Partners health care system (2000 through 2010). A novel artificial intelligence program was trained and validated through manual review of medical records.

The researchers found that common comorbid conditions included autoimmune diagnoses (thyroid disease in 14.6 percent, diabetes mellitus in 11.1 percent, in 6.3 percent, in 4.3 percent, rheumatoid arthritis in 3.9 percent, and psoriasis and psoriatic arthritis in 2.0 percent); atopy (allergic rhinitis, asthma, and/or eczema in 38.2 percent and contact dermatitis and other eczema in 35.9 percent); and (depression or anxiety in 25.5 percent). High prevalence of hyperlipidemia (24.5 percent), hypertension (21.9 percent), and (17.3 percent) were also seen. A comparison psoriasis and psoriatic arthritis group yielded a different profile.

"Physicians caring for patients with alopecia areata should consider screening for comorbid conditions," the authors write.

One author disclosed financial ties to the pharmaceutical industry.


Explore further

Psoriasis tied to 14 other autoimmune diseases

More information: Abstract
Full Text (subscription or payment may be required)

Health News Copyright © 2013 HealthDay. All rights reserved.

Citation: Comorbidities common with alopecia areata (2013, May 24) retrieved 12 December 2019 from https://medicalxpress.com/news/2013-05-comorbidities-common-alopecia-areata.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments